Vascular impotence is a common medical problem for which available therapies are limited. Three impotent patients observed in the authors' practice who were receiving pentoxifylline for treatment of claudication of the lower extremities spontaneously reported improved sexual function. A controlled trial of pentoxifylline for vascular impotence may be warranted.
Get full access to this article
View all access options for this article.
References
1.
Pentoxifylline for intermittent claudication. TheMedical Letter26:103-104, 1984.
2.
Ward A., Clissold SP: Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs34:50-97, 1987.
3.
Spittell JA: Pentoxifylline and intermittent claudication. Ann Intern Med102:126, 1985.
4.
Virag R., Bouilly P., Frydman G.: Is impotence a vascular disorder?Lancet1:181-184, 1985.
5.
Korenman SG, Mooradian AD, Kaiser FE, et al: Treatment of vasculogenic sexual dysfunction with pentoxifylline . Clin Res36:123A, 1988.
6.
Ambrus JL, Ambrus CM, Mahfzah M., et al: Mechanism of the potentiation of thrombolysis by pentoxifylline (Trental). J Med18:265-276, 1987.
7.
Seiffge D., Weithmann KU: Surprising effects of the sequential administration of pentoxifylline and low dose acetylsalicylic acid on thrombus formation. Thromb Res46:371-383, 1987.
